Brielle Benyon
Articles
FDA Approves Melphalan Flufenamide Combo for Triple-Refractory Myeloma
February 27, 2021
Article
The FDA approved melphalan flufenamide (Pepaxto; melflufen) plus dexamethasone for adults with triple-refractory multiple myeloma.
FDA Approves Frontline Cemiplimab-rwlc for Advanced Lung Cancer
February 22, 2021
Article
The FDA approved single-agent frontline cemiplimab-rwlc (Libtayo) for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with a PD-L1 expression of 50% or greater.
Patient Perceptions, Other Factors Linked to Fear of Recurrence
February 19, 2021
Article
Fear of cancer recurrence is a common plight for people after they have completed cancer treatment, and recent research analyzed which patient characteristics were associated with higher rates of fear of recurrence.
COVID-19 Misinformation: Parents of Patients May Fall for It
February 18, 2021
Article
Parents of pediatric patients with cancer were more likely to believe COVID-19 misinformation than parents of children without cancer.
High TMB, Adverse Events May Predict Immunotherapy Response in mUC
February 17, 2021
Article
Patients with metastatic urothelial carcinoma with higher tumor mutational burden and who experienced immune-related adverse events tended to have higher response rates to immune checkpoint inhibitor.
COVID-19 Amplifies Stress, Loneliness in Cancer Survivors
February 12, 2021
Article
The COVID-19 pandemic increased rates of stress in the general public, adding to that of survivors who may already be feeling anxious.
Discuss Mental Health in Testicular Cancer Survivorship Plans
February 06, 2021
Article
Testicular cancer survivors had a higher rate of mental health service utilization than their healthy counterparts.
FDA Approves Umbralisib for Relapsed/Refractory MZL and FL
February 06, 2021
Article
The FDA approved umbralisib (Ukoniq) for the treatment of adults with relapsed/refractory marginal zone lymphoma (MZL) who had at least 1 prior anti-CD20—based regimen; and adults with relapsed/refractory follicular lymphoma (FL) who had at least 3 prior lines of systemic therapy.
Nurses Share Inspiration on World Cancer Day
February 04, 2021
Article
Hear from other oncology nurses on what their career means to them, and how they overcame challenges in the last year.